Comparability of Microarray Data between Amplified and Non Amplified RNA in Colorectal Carcinoma

Table 2

Different gene expression values of cancer specific genes between non amplified (NA) and amplified (PA) RNA samples from colorectal carcinoma samples.

Affy	Gb	Bases	Anotation	Avg. Signals NA	Avg. Signals PA	FC PA/NA	𝑃
221455_s_at	NM_030753	56038	Wingless-type MMTV integration site family, member 3 (WNT3).	20	78	4	.04
212447_at	AF161402	23,589	HSPC284 mRNA, partial cds.	2480	9611	4	.01
201111_at	NM_001253	50,649	Brain cellular apoptosis susceptibility protein (CSE1).	2568	7431	3	.01
209056_s_at	NM_001253	62,329	CDC5 (cell division cycle 5, S. pombe, homolog)-like (CDC5L).	1399	3861	3	.01
206458_s_at	NM_024494	54,746	Wingless-type MMTV integration site family, member 2B (WNT2B).	72	177	2	.01
207149_at	L33477	1,102,757	Br-cadherin mRNA, complete cds.	35	84	2	.04
204731_at	NM_003243	225,660	Transforming growth factor, beta receptor III (TGFBR3).	602	1336	2	.04
219226_at	NM_016507	73,062	CDC2-related protein kinase 7 (CrkRS).	555	1131	2	.01
217366_at	Z37994	3620	Alpha E-catenin pseudogene.	30	6	‒2	.04
208504_x_at	NM_018931	3321	Protocadherin beta 11 (PCDHB11).	33	11	‒2	.04
201069_at	NM_004530	27,516	Matrix metalloproteinase 2 (MMP2).	1528	887	−2	.04
203968_s_at	NM_001254	15,268	Cell division cycle 6 (CDC6).	624	338	−2	.01
203918_at	NM_002587	25,296	Protocadherin 1 (PCDH1).	544	290	−2	.04
208756_at	U36764	9235	TGF-beta receptor interacting protein 1.	4451	2355	−2	.01
210838_s_at	L17075	15,944	TGF-b superfamily receptor type I.	277	127	−2	.01
206943_at	NM_004612	49,063	Transforming growth factor, beta receptor I (TGFBR1).	331	150	−2	.01
212143_s_at	BF340228	9028	Insulin-like growth factor binding protein 3.	1192	462	−3	.01
202039_at	NM_004740	2089	TGFB1-induced antiapoptotic factor 1 (TIAF1).	1000	371	−3	.01
203214_x_at	NM_001786	18927	Cell division cycle 2, G1 to S and G2 to M (CDC2).	3181	1174	−3	.01
160020_at	Z48481	11,011	Membrane-type matrix metalloproteinase 1 (MMP1).	1258	437	−3	.01
217010_s_at	AF277724	46,558	Cell division cycle 25C splice variant 3 (CDC25C).	211	61	−3	.01
204696_s_at	NM_001789	31,134	Cell division cycle 25A (CDC25A).	123	34	−4	.01
203527_s_at	NM_000038	108,353	Adenomatosis polyposis coli (APC).	85	23	−4	.01
210287_s_at	U01134	192,877	Soluble vascular endothelial cell growth factor receptor (sflt).	143	37	−4	.01
203878_s_at	NM_005940	11,468	Matrix metalloproteinase 11 (stromelysin 3) (MMP11).	1546	400	−4	.01
203365_s_at	NM_002428	21,524	Matrix metalloproteinase 15 (membrane-inserted) (MMP15).	388	93	−4	.04
203683_s_at	NM_003377	3994	Vascular endothelial growth factor B (VEGFB).	422	78	−5	.01
217279_x_at	X83535	11,011	Membrane-type matrix Metalloproteinase (MMP14).	244	27	−9	.01
204380_s_at	M58051	15,565	Fibroblast growth factor receptor (FGFR3).	224	25	−9	.01
207334_s_at	NM_003242	87,641	Transforming growth factor, beta receptor II (TGFBR2).	323	15	−16	.01